The cycling of combination antirheumatic drug therapy in rheumatoid arthritis

A. C. Schwarzer; M. H. Arnold; D. Kelly; M. Jones; E. Beller; P. J. Mcnaught; L. Schrieber; P. M. Brooks

doi:10.1093/rheumatology/29.6.445

The cycling of combination antirheumatic drug therapy in rheumatoid arthritis

A. C. Schwarzer^*, M. H. Arnold, D. Kelly, M. Jones, E. Beller, P. J. Mcnaught, L. Schrieber, P. M. Brooks

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

11 Citations (Scopus)

Abstract

In this open pilot study a combination of hydroxychioroquine, prednisolone and alternating months of treatment with sulphasalazine or oral weekly pulse methotrexate has been investigated in 16 patients with rheumatoid arthritis (RA) refractory to a total of 67 disease suppressive medications. Results at 3 months indicated significant improvements in visual analogue score for pain, joint count, Ritchie index, scale of disability related to activities of daily living, ESR, rheumatoid factor and C-reactive protein. This degree of improvement, however, was not maintained 6 and 12 months after commencement of treatment. Pain score, Ritchie index and ESR were the only parameters demonstrating significant improvement at 12 months. Therapy was terminated in eight patients, half due to lack of efficacy and half because of side effects.

Original language	English
Pages (from-to)	445-450
Number of pages	6
Journal	Rheumatology
Volume	29
Issue number	6
DOIs	https://doi.org/10.1093/rheumatology/29.6.445
Publication status	Published - Dec 1990
Externally published	Yes

Access to Document

10.1093/rheumatology/29.6.445

Cite this

@article{8f7a00c873cc490ea357e3d3c9a68762,

title = "The cycling of combination antirheumatic drug therapy in rheumatoid arthritis",

abstract = "In this open pilot study a combination of hydroxychioroquine, prednisolone and alternating months of treatment with sulphasalazine or oral weekly pulse methotrexate has been investigated in 16 patients with rheumatoid arthritis (RA) refractory to a total of 67 disease suppressive medications. Results at 3 months indicated significant improvements in visual analogue score for pain, joint count, Ritchie index, scale of disability related to activities of daily living, ESR, rheumatoid factor and C-reactive protein. This degree of improvement, however, was not maintained 6 and 12 months after commencement of treatment. Pain score, Ritchie index and ESR were the only parameters demonstrating significant improvement at 12 months. Therapy was terminated in eight patients, half due to lack of efficacy and half because of side effects.",

author = "Schwarzer, {A. C.} and Arnold, {M. H.} and D. Kelly and M. Jones and E. Beller and Mcnaught, {P. J.} and L. Schrieber and Brooks, {P. M.}",

year = "1990",

month = dec,

doi = "10.1093/rheumatology/29.6.445",

language = "English",

volume = "29",

pages = "445--450",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - The cycling of combination antirheumatic drug therapy in rheumatoid arthritis

AU - Schwarzer, A. C.

AU - Arnold, M. H.

AU - Kelly, D.

AU - Jones, M.

AU - Beller, E.

AU - Mcnaught, P. J.

AU - Schrieber, L.

AU - Brooks, P. M.

PY - 1990/12

Y1 - 1990/12

N2 - In this open pilot study a combination of hydroxychioroquine, prednisolone and alternating months of treatment with sulphasalazine or oral weekly pulse methotrexate has been investigated in 16 patients with rheumatoid arthritis (RA) refractory to a total of 67 disease suppressive medications. Results at 3 months indicated significant improvements in visual analogue score for pain, joint count, Ritchie index, scale of disability related to activities of daily living, ESR, rheumatoid factor and C-reactive protein. This degree of improvement, however, was not maintained 6 and 12 months after commencement of treatment. Pain score, Ritchie index and ESR were the only parameters demonstrating significant improvement at 12 months. Therapy was terminated in eight patients, half due to lack of efficacy and half because of side effects.

AB - In this open pilot study a combination of hydroxychioroquine, prednisolone and alternating months of treatment with sulphasalazine or oral weekly pulse methotrexate has been investigated in 16 patients with rheumatoid arthritis (RA) refractory to a total of 67 disease suppressive medications. Results at 3 months indicated significant improvements in visual analogue score for pain, joint count, Ritchie index, scale of disability related to activities of daily living, ESR, rheumatoid factor and C-reactive protein. This degree of improvement, however, was not maintained 6 and 12 months after commencement of treatment. Pain score, Ritchie index and ESR were the only parameters demonstrating significant improvement at 12 months. Therapy was terminated in eight patients, half due to lack of efficacy and half because of side effects.

UR - http://www.scopus.com/inward/record.url?scp=0025643331&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/29.6.445

DO - 10.1093/rheumatology/29.6.445

M3 - Article

C2 - 2257452

AN - SCOPUS:0025643331

SN - 1462-0324

VL - 29

SP - 445

EP - 450

JO - Rheumatology

JF - Rheumatology

IS - 6

ER -

The cycling of combination antirheumatic drug therapy in rheumatoid arthritis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this